Melbourne, Apr 2, 2008 (ABN Newswire) - The Directors of Solagran Limited (ASX: SLA)(PNK: SOGRF) are pleased to announce details of the path forward that the Board has adopted for the marketing of Ropren in Russia, and at the same time advise the market that Solagran has terminated discussions with the Menarini Group in relation to a potential strategic partnership.
